About this trial
This study examines the association of variability in glucose values over a 10-day period with cognitive function and functional status among individuals with prediabetes, aged 50 or older.
Eligibility criteria
Qualifiers
Aged 50 years and older
At least 8th grade education
Disqualifiers
Diagnosed type 1 or type 2 diabetes
Current use of mediation for diabetes (oral hypoglycemic agents, insulin), or with diabetic properties (e.g., steroids)
Chronic disorders (cardiovascular disease, peripheral vascular disease, stroke, transient ischemic attack, chronic kidney disease, past year cancer)
Neurological disorders (e.g., Parkinson's, epilepsy, multiple sclerosis)
Trial design
Treatments tested in this trial
- Continuous Glucose Monitoring System (CGMS)
Treatment groups
Sponsors and collaborators
University of Maryland, Baltimore
Lead sponsor
Baltimore VA Medical Center
Collaborator
University of Maryland, Baltimore County
Collaborator